RSAD2 and systemic sclerosis: Several studies have demonstrated that RSAD2 showed hypomethylation and overexpression in blood from SSc patients (Tan et al., 2006; Bos et al., 2009; Assassi et al., 2010; Bodewes et al., 2018).